Text · Amendment list
Framework for strengthening the availability and security of supply of critical medicinal products as well as the availability of, and accessibility of, medicinal products of common interest
Report A-10-2025-0272-AM-253-255 · COM(2025)0102 – C10-0048/2025 – 2025/0102(COD)
- Kind
- Amendment list A-10-2025-0272-AM-253-255
- Date
- 14 January 2026
- Dossier
- 2025/0102(COD)
More facts (2)
- Formats
- Official page PDF Word
- Reference
- COM(2025)0102 – C10-0048/2025 – 2025/0102(COD)
Text
The text as parsed from the official Word file. Every paragraph has a link (¶) and can be saved to a project as a passage.
| Text proposed by the Commission | Amendment |
|---|---|
| (42 a) The availability of critical medicines might be affected by Union legislation in other sectors, in particular environmental legislation such as the Urban Wastewater Treatment Directive. In order to ensure coherence and avoid unintended consequences leading to shortages, it is important to assess the impact of such measures on the supply of medicines. |
Framework for strengthening the availability and security of supply of critical medicinal products as well as the availability of, and accessibility of, medicinal products of common interest
| Text proposed by the Commission | Amendment |
|---|---|
| Article12a | |
| Coordination with environmental and chemical legislation | |
| The Commission and the Member States shall ensure that the application of this Regulation is coordinated with existing and forthcoming environmental and chemical legislation to prevent unintended restrictions on the manufacturing and availability of critical medicinal products and ensure the future availability of critical medicinal products, while maintaining the best possible environmental and health standards. | |
| Where such legislation is likely to create substantial barriers to the continued production or availability of critical medicinal products, the Commission shall conduct a coordinated impact assessment and consult with the Critical Medicines Coordination Group, the Member States and relevant stakeholders to propose mitigating actions including possible regulatory proposals. |
Framework for strengthening the availability and security of supply of critical medicinal products as well as the availability of, and accessibility of, medicinal products of common interest
| Text proposed by the Commission | Amendment |
|---|---|
| 2 a. The Commission shall carry out a yearly assessment of the impact of the Urban Wastewater Treatment Directive, and in particular of the extended producer responsibility provisions set out in Article 9 and 10 thereof and Annex III thereto, on the availability or security of supply of critical medicines in the Union. Where such assessments identify a negative impact on the availability of critical medicines, Member States shall temporarily suspend the application of the extended producer responsibility provisions until appropriate mitigating measures are adopted. |
Connections
The dossier, the decisions on this text and its other versions.
No connections found for this item.
Sources & citation
Where the facts on this page come from, and how to cite it.
- Data source
- Licensed CC BY 4.0.
- Retrieved
- 25 September 2026
Cite as
European Parliament (2026). “A10-0272/253 - Amendement 253 - Michele Picaro, Francesco Torselli, Mariateresa Vivaldini, Aurelijus Veryga, Ruggero Razza - au nom du groupe ECR - Rapport A10-0272/2025 - Tomislav Sokol - Cadre visant à renforcer la disponibilité et la sécurité de l’approvisionnement en médicaments critiques ainsi que la disponibilité et l’accessibilité des médicaments d’intérêt commun - (COM(2025)0102 - C10-0048/2025 - 2025/0102(COD))”. Text, 14 January 2026. docId A-10-2025-0272-AM-253-255, reference A10-0272/2025. EU Parl Watch Research. https://news.eu-parl.st-solutions.dev/texts/A-10-2025-0272-AM-253-255 (retrieved 25 September 2026). Data: EP Open Data API: document record, https://data.europarl.europa.eu/api/v2/documents/A-10-2025-0272-AM-253-255 (CC BY 4.0).
BibTeX
@misc{epw-text-a-10-2025-0272-am-253-255,
author = {{European Parliament}},
title = {{A10-0272/253 - Amendement 253 - Michele Picaro, Francesco Torselli, Mariateresa Vivaldini, Aurelijus Veryga, Ruggero Razza - au nom du groupe ECR - Rapport A10-0272/2025 - Tomislav Sokol - Cadre visant à renforcer la disponibilité et la sécurité de l’approvisionnement en médicaments critiques ainsi que la disponibilité et l’accessibilité des médicaments d’intérêt commun - (COM(2025)0102 - C10-0048/2025 - 2025/0102(COD))}},
year = {2026},
date = {2026-01-14},
howpublished = {\url{https://news.eu-parl.st-solutions.dev/texts/A-10-2025-0272-AM-253-255}},
url = {https://news.eu-parl.st-solutions.dev/texts/A-10-2025-0272-AM-253-255},
urldate = {2026-09-25},
publisher = {EU Parl Watch Research},
note = {Text. docId A-10-2025-0272-AM-253-255, reference A10-0272/2025. Data: EP Open Data API: document record (CC BY 4.0)}
}